The relationship between treatment-induced hypertension and efficacy of anlotinib in recurrent or metastatic esophageal squamous cell carcinoma

OBJECTIVE: In this post-hoc analysis, we evaluated anlotinib treatment-induced hypertension as a potential predictive factor of efficacy in esophageal squamous cell carcinoma (ESCC) patients. METHODS: A total of 109 patients enrolled in the anlotinib group in a phase 2 trial were included. The tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Yan, Xiao, Juxiang, Fang, Wentao, Lu, Ping, Fan, Qingxia, Shu, Yongqian, Feng, Jifeng, Zhang, Shu, Ba, Yi, Zhao, Yang, Liu, Ying, Bai, Chunmei, Bai, Yuxian, Tang, Yong, He, Jie, Huang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185854/
https://www.ncbi.nlm.nih.gov/pubmed/33724741
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185854/
https://www.ncbi.nlm.nih.gov/pubmed/33724741
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0187

Ejemplares similares